Secondary analysis of gut hormone data from children with and without in utero exposure to gestational diabetes: Differences in the associations among ghrelin, GLP-1, and insulin secretion
- PMID: 33236516
- PMCID: PMC8105267
- DOI: 10.1111/ijpo.12757
Secondary analysis of gut hormone data from children with and without in utero exposure to gestational diabetes: Differences in the associations among ghrelin, GLP-1, and insulin secretion
Abstract
Background: Intrauterine exposure to gestational diabetes mellitus (GDM) increases risk for type 2 diabetes (T2D). Ghrelin and GLP-1 have opposite functions in nutritional homeostasis and are associated with insulin secretion, but it is not known if individuals exposed to GDM exhibit dysregulation in these associations.
Objective: Test the hypothesis that children exposed to GDM in utero will exhibit dysregulation among ghrelin, GLP-1, and C-peptide (reflecting insulin secretion).
Methods: Data from N = 43 children aged 5 to 10 years were included in this secondary analysis of ghrelin, GLP-1, and C-peptide response to a liquid meal test. Repeated measures mixed model analyses were used to measure associations among hormones.
Results: The association of ghrelin and GLP-1 was moderated by GDM group (P < .01), such that ghrelin was inversely associated with GLP-1 in children without GDM exposure, but not for those exposed to GDM. GLP-1 was positively associated with C-peptide in both groups, but the association was stronger in those exposed to GDM (estimate = 1.06 vs 1.01).
Conclusions: Differences in the associations among ghrelin, GLP-1, and C-peptide displayed here suggest novel lines of research about whether the regulation of gut hormones and insulin secretion contribute to obesity and risk for T2D in children exposed to GDM.
Keywords: GLP-1; gestational diabetes; ghrelin; insulin secretion.
© 2020 World Obesity Federation.
Conflict of interest statement
Figures

Similar articles
-
Gut hormone activity of children born to women with and without gestational diabetes.Pediatr Obes. 2014 Feb;9(1):53-62. doi: 10.1111/j.2047-6310.2012.00140.x. Epub 2013 Jan 31. Pediatr Obes. 2014. PMID: 23364910 Free PMC article.
-
Normal secretion of the incretin hormones glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 during gestational diabetes mellitus.Gynecol Endocrinol. 2007 Jan;23(1):58-62. doi: 10.1080/09513590601137004. Gynecol Endocrinol. 2007. PMID: 17484514
-
Glucagon-like peptide-1 secretion in women with gestational diabetes mellitus during and after pregnancy.J Endocrinol Invest. 2011 Oct;34(9):e287-90. doi: 10.3275/7799. Epub 2011 Jun 7. J Endocrinol Invest. 2011. PMID: 21666414
-
The role of glucagon-like peptide-1 impairment in obesity and potential therapeutic implications.Diabetes Obes Metab. 2014 Jan;16(1):9-21. doi: 10.1111/dom.12119. Epub 2013 May 26. Diabetes Obes Metab. 2014. PMID: 23617798 Review.
-
Is glucagon-like peptide 1 an incretin hormone?Diabetologia. 1999 Mar;42(3):373-9. doi: 10.1007/s001250051165. Diabetologia. 1999. PMID: 10096792 Review.
References
-
- Casagrande SS, Linder B, Cowie CC. Prevalence of gestational diabetes and subsequent Type 2 diabetes among U.S. women. Diabetes research and clinical practice. 2018;141:200–208. - PubMed
-
- Kitzmiller JL, Dang-Kilduff L, Taslimi MM. Gestational Diabetes After Delivery. Diabetes Care. 2007;30(Supplement 2):S225. - PubMed
-
- Metzger BE. Long-term outcomes in mothers diagnosed with gestational diabetes mellitus and their offspring. Clinical obstetrics and gynecology. 2007;50(4):972–979. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical